U.S. Markets open in 4 hrs 9 mins

These 3 Stocks Shot Up 50% in 2017 -- Are They Still Buys?

Demitrios Kalogeropoulos, George Budwell, and Dan Caplinger, The Motley Fool

Most financial literature stresses the point that impressive past financial returns don't guarantee good results in the future. And while that's strictly true, market-thumping stock price growth often results from the type of fundamental improvements in a company's business that can drive many years of gains.

With that in mind, we asked Motley Fool investors to scour the pool of recent high-flying stocks for investments that might keep rising. Read on to find out why Boeing (NYSE: BA), Constellation Brands (NYSE: STZ), and Geron (NASDAQ: GERN) topped this list.

A space shuttle taking off.

Image source: Getty Images.

This stock keeps flying higher

Dan Caplinger (Boeing): You don't often see stocks in the Dow Jones Industrial Average make aggressive upward moves over short periods of time, but Boeing gained a lot of altitude in 2017. The aerospace giant saw its shares soar almost 90% last year, riding the wave of aircraft orders from an airline industry that's healthier than it's been in decades. With plenty of available cash flow, buyers are investing in new aircraft to modernize their fleets and increase efficiency, and Boeing's new models are among the most popular in the world. Boeing's strength has continued into 2018, with the stock higher by more than 20% so far this year as well.

Fundamentally, Boeing is doing a lot of things right. Moves to emphasize its most popular lines of aircraft and to look at internal efficiency gains have had a big impact on margin for its key commercial business, and that's boosting profit substantially. In particular, the workhorse 737 series of planes has been more popular than ever, and new variants are getting a lot of attention from buyers. Add to that expected demand for wide-body models like the 757, 767, and 777, and Boeing seems to have its engines revved up for maximum growth. As long as airlines continue to thrive, Boeing and its shareholders should keep reaping the rewards.

An attractive risk-to-reward ratio

George Budwell (Geron Corporation): Geron Corporation has nearly doubled in value so far this year, but the best may be yet to come for this tiny drugmaker. If you're not familiar with this story, Geron is developing a first-in-class telomerase inhibitor called imetelstat with the biopharma giant Johnson & Johnson for two blood cancers known as myelofibrosis (MF) and myelodyspastic syndromes (MDS).

J&J currently owns an exclusive global license to the drug and the company is expected to decide whether to keep this license by the end of the third quarter of this year. In short, Geron is staring down a critical binary event that could make or break its stock later this year. 

The good news, though, is that imetelstat seems to be bending the curve in terms of overall survival for its MF indication, and generating substantial improvements in patients with MDS as well. The downside is that J&J is keeping a tight lid on the results for both trials; so investors won't known anything concrete until the company unveils its Continuation Decision regarding the collaboration in Q3. 

Now, if J&J walks, Geron will have to make some tough choices. After a recent capital raise, for instance, the biotech seems to have enough cash to at least get imetelstat's planned late-stage trial in MDS under way, but the drug's MF indication would almost certainly be tabled in the event J&J cuts bait. But the silver lining here is that Geron no longer appears to be in imminent danger of folding if J&J does end the collaboration.

So, with a viable path forward on the table in a worst-case scenario, and a monstrous short-squeeze possible if J&J decides to stay the course, Geron's stock appears to offer a rather enticing risk-to-reward ratio right now. That said, this penny biotech stock is arguably only suited for the most aggressive of investors due to the strong possibility that its shares will tank -- at least temporarily -- if J&J leaves the picture. 

More gains ahead for this alcoholic beverage giant

Demitri Kalogeropoulos (Constellation Brands): The broader beer industry saw little growth last year, but Constellation Brands' impressive sales and profitability gains left peers like Anheuser-Busch InBev, Molson Coors, and even Boston Beer far behind. In fact, its imported beers like Corona and Modelo were responsible for most of the industry's growth in 2017, and Constellation Brands amplified that success by boosting selling prices and lifting its operating margin to a new high.

Friends drinking beer at a bar.

Image source: Getty Images.

After five consecutive years of 20% or better earnings growth, Constellation Brands is on track for a significant slowdown this year. Management is targeting a 10% profit increase in 2018 as they spend aggressively on marketing support for core beer and wine products and for promoting the launch of Corona Premier, the first national expansion of that brand in over 25 years.

Yet Constellation Brands still looks like a good buy today. Its beer business is expected to grow at a healthy 10% pace this year while the wine and spirits segment boosts sales and profitability. Looking further out, the company's massive capacity expansion project should soon start reducing costs, and investors can also look forward to increased direct cash returns in the coming years now that the capital spending has peaked. There's the potential that the company will profit from the sale of marijuana, too, as its legalization begins to open the door to edible cannabis products starting in 2019.

More From The Motley Fool

Dan Caplinger owns shares of Boeing. Demitrios Kalogeropoulos owns shares of Boston Beer. George Budwell owns shares of Geron. The Motley Fool owns shares of and recommends Anheuser-Busch InBev NV and Boston Beer. The Motley Fool owns shares of Johnson & Johnson and Molson Coors Brewing. The Motley Fool has a disclosure policy.

  • 7 Stocks to Buy and Hold Through Any Market Selloff
    Business
    InvestorPlace

    7 Stocks to Buy and Hold Through Any Market Selloff

    Last week’s market collapse made headlines throughout the world. Since the sharp correction has negatively impacted virtually all investment sectors, you’re going to find discounted deals everywhere you look.

  • YouTube goes down for more than an hour
    Business
    Associated Press

    YouTube goes down for more than an hour

    YouTube's video streaming service went out for more than an hour on Tuesday, apparently affecting locations around the world. YouTube acknowledged the outage in a tweet at 9:41 p.m. EDT, noting that it affected YouTube, YouTube Music and YouTube TV. Reporters for the AP found that YouTube's main service was working again around 10:50 p.m. EDT.

  • Brits Are All Making the Same Joke About the New Royal Baby
    News
    Time

    Brits Are All Making the Same Joke About the New Royal Baby

    Meghan Markle, the Duchess of Sussex, is expecting her first child with Prince Harry. The news, announced Monday morning by Kensington Palace, has already been greeted by hundreds of messages of congratulations for the royal couple on social media. The U.K. is set to leave the European Union on March 29, exactly two years after Prime Minister Theresa May started the formal process for doing so by invoking Article 50 of the Lisbon Treaty.

  • Netflix is ditching freeloaders from subscriber forecasts after volatile stock moves
    Business
    MarketWatch

    Netflix is ditching freeloaders from subscriber forecasts after volatile stock moves

    After two consecutive quarters of missing the mark on its own forecasts for subscriber growth, Netflix Inc. hopes to put an end to the big swings in its stock with some changes in its accounting. In kicking off tech’s earnings season Tuesday, Netflix (NFLX) reported better-than-expected subscriber growth in the quarter, leading to an 11% jump in its shares in after-hours trading. Three months ago, Netflix reported weaker-than-expected subscriber growth, sending its stock tumbling around 12% in the next trading day.

  • Boeing delivers first 737 Max 8 BBJ and unveils Max 7 luxury interior (Photos)
    Business
    American City Business Journals

    Boeing delivers first 737 Max 8 BBJ and unveils Max 7 luxury interior (Photos)

    Boeing has delivered its very first 737 Max 8 business jet to a paying customer. It's the first of 20 BBJ Max jets that buyers from around the world have ordered from the Chicago-based jetmaker since they went on sale. Boeing spokesman Dmitry Krol declined to identify the buyer of the jet, which is the second of its kind made at Boeing's Renton 737 factory.

  • Marijuana Stocks to Watch in October -- and Into 2019
    World
    Motley Fool

    Marijuana Stocks to Watch in October -- and Into 2019

    Tomorrow, Wednesday, Oct. 17, Canada will become the first industrialized county in the world where marijuana is legal for adult recreational use -- and only the second country, along with Uruguay, where such use is legal.  Not only does this open up

  • Here's the Average Social Security Benefit for 2019
    Business
    Motley Fool

    Here's the Average Social Security Benefit for 2019

    Millions of seniors collect Social Security, and without it, they'd be underwater on their bills. At present, the average retiree gets $1,422 a month in Social Security benefits. There's a world of misinformation surrounding Social Security, and perhaps one of the most detrimental myths out there is the notion that the program is enough to sustain seniors by itself.

  • Jamal Khashoggi was accidentally killed during interrogation: report
    World
    Fox Business Videos

    Jamal Khashoggi was accidentally killed during interrogation: report

    Fox Business foreign policy analyst Walid Phares on the report that Saudi journalist Jamal Khashoggi was accidentally killed.

  • General Electric (GE) Stock Sinks As Market Gains: What You Should Know
    Finance
    Zacks

    General Electric (GE) Stock Sinks As Market Gains: What You Should Know

    With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

  • Sears soars 36% — one day after filing for bankruptcy (SHLD)
    Finance
    Business Insider

    Sears soars 36% — one day after filing for bankruptcy (SHLD)

    The retailer received approval on Tuesday to access a $300 million loan to keep it afloat during bankruptcy. Sears Holdings soared as much as 124% — one day after filing for bankruptcy — as the embattled retailer received approval to access a $300 million loan to keep it afloat during bankruptcy.

  • Where Will NVIDIA Be in 5 Years?
    Business
    Motley Fool

    Where Will NVIDIA Be in 5 Years?

    At one time, NVIDIA (NASDAQ: NVDA) floated under the radar in the technology sector. Its graphics processing units (GPUs) were then niche tech products that appealed mainly to graphic artists and hardcore PC gamers, but that all changed over the last

  • Saudi Arabia using the 'oil weapon option' could cause prices to soar to $150
    World
    Business Insider

    Saudi Arabia using the 'oil weapon option' could cause prices to soar to $150

    Analysts see a 1973-style embargo as unlikely, but warn oil prices could hit triple-digits if tensions escalate. "We believe that Saudi leadership would be extremely reluctant to exercise the oil weapon option, as its reputation as the world’s stable, reliable oil central banker would be severely undercut," RBC analysts wrote in a research note.

  • Why MannKind Corp. Soared 16.4% Tuesday
    Business
    Motley Fool

    Why MannKind Corp. Soared 16.4% Tuesday

    After MannKind Corp. (NASDAQ: MNKD) announced that it closed on its planned collaboration agreement with United Therapeutics (NASDAQ: UTHR), its shares rallied 16.4% on Tuesday. MannKind only has one Food and Drug Administration (FDA)-approved drug to its name, Afrezza, an inhalable insulin. Afrezza was launched in 2015 and sales have been far shy of optimistic pre-launch forecasts.

  • Call of the day: Tilray as Benchmark starts coverage with bullish rating
    Business
    Yahoo Finance Video

    Call of the day: Tilray as Benchmark starts coverage with bullish rating

    Benchmark initiated its coverage of Tilray with a 'buy' rating and a $200 price target. Analyst Mike Hickey said he's bullish on the cannabis company's early leadership in the medical cannabis market in Canada and its strategic alliance with Novartis.

  • 3 Top Large-Cap Stocks to Buy in October
    Business
    Motley Fool

    3 Top Large-Cap Stocks to Buy in October

    If you're looking for high-quality large-cap stocks to add to your portfolio this month, three of our Motley Fool contributors have some ideas. Here's why you should consider Berkshire Hathaway (NYSE: BRK.B), Cisco Systems (NASDAQ: CSCO), and AT&T (NYSE: T). Tyler Crowe (Berkshire Hathaway): Perhaps one of the most ridiculous investment takes out there right now is that Berkshire Hathaway's immense cash pile isn't a good thing.

  • Walmart is aggressively shifting away from its most legendary shopping format
    Finance
    Yahoo Finance

    Walmart is aggressively shifting away from its most legendary shopping format

    Walmart (WMT) continues to kill off the American shopping creation it’s most known for, the massive supercenter that sells everything under one roof. With the U.S. market already having more than 3,500 Walmart supercenters and a focus by CEO Doug McMillon to increase spending on eCommerce and India, Walmart said Tuesday it will open a mere 10 supercenters in 2019. The company has reduced emphasis on the store format pioneered by founder Sam Walton – which could average a gargantuan 178,000 square feet – in recent years.

  • A Look at AT&T’s Dividends
    Business
    Market Realist

    A Look at AT&T’s Dividends

    What Investors Should Know about AT&T’s Growth Prospects (Continued from Prior Part) Shareholder returns Increasing capital returns to shareholders is one of AT&T’s (T) main priorities. In the second quarter, the company returned $3.1 billion to shareholders

  • Finance
    CNBC

    Morgan Stanley: The stock sell-off is going to get worse

    The stock market is in the middle of a rolling bear market, says Morgan Stanley's Mike Wilson. "It's being caused by a drain in liquidity and peaking growth," Wilson says. The stock market sell-off is only going to get worse, predicts Morgan Stanley's chief U.S. equity strategist, Mike Wilson.

  • These are the bad things about early retirement that no one talks about
    News
    MarketWatch

    These are the bad things about early retirement that no one talks about

    For all the glamour of living an early retirement lifestyle, there are plenty of negatives I’ve come to discover since I permanently left my job in 2012. As a result, you’re repeatedly forced to will yourself into action.

  • What Is Saudi Arabia's Grand Plan for Pakistan?
    World
    The National Interest

    What Is Saudi Arabia's Grand Plan for Pakistan?

    Saudi Arabia's strategic use of aid and investment has heightened under Crown Prince Mohammed bin Salman’s influence. What Is Saudi Arabia's Grand Plan for Pakistan? Pakistan’s new government has been in a mad dash to attract foreign aid and investment—most notably from Saudi Arabia—to offset a widening current account deficit, rising foreign debt repayment obligations, and avert a balance of payments crisis. Pakistan’s external financing needs will approach or exceed $30 billion this fiscal year.

  • Business
    InvestorPlace

    30 Marijuana Stocks to Buy as the Future Turns Green

    With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. For instance, some of the top marijuana stocks are levered toward medical cannabis.

  • Weed stocks are under pressure on the eve of Canada's legalization (CGC, TLRY)
    Business
    Business Insider

    Weed stocks are under pressure on the eve of Canada's legalization (CGC, TLRY)

    After previously setting record highs, Canopy Growth and Aurora Cannabis had fallen into the red alongside the entire sector. Canada will become the first developed country to legalize recreational cannabis on Wednesday, but with mere hours left before the first sales are legal, many of the largest marijuana stocks were seeing red. Canopy Growth, Aurora Cannabis, and Tilray — collectively the three largest producers by market cap — had all fallen into the red by midday Tuesday, hours after Canopy and Aurora soared to record highs.

  • The Largest Private Employer in the World May Soon Sell Marijuana Products
    Business
    Motley Fool

    The Largest Private Employer in the World May Soon Sell Marijuana Products

    With literally hours remaining, Canada is set to lift the curtain on nine decades of recreational marijuana prohibition tomorrow. This makes Canada the first industrialized country in the world to legalize adult-use weed. As you might rightly imagine, investors can't wait for this legalization to take place.

  • Marijuana stocks to watch: Canopy Growth is the cannabis business’s $4 billion gorilla
    Business
    MarketWatch

    Marijuana stocks to watch: Canopy Growth is the cannabis business’s $4 billion gorilla

    The following article is part of a package of stories that MarketWatch is publishing to mark the start of full legalization of cannabis for adult use in Canada on Wednesday. Smith Falls, Ontario–based Canopy Growth Corp. made headlines and drove cannabis stocks to new heights over the summer when it announced that Corona brewer Constellation Brands Inc. was going to invest an additional $4 billion in the company. Billed by both companies as a strategic partnership, the additional $4 billion investment adds to the 9.9% stake that Constellation bought in October of last year and sets the company up to either be bought outright by Constellation — via warrants that could increase its stake to more than 50% — or continue to work with the beverage company to create a range of consumer-focused cannabis products that may one day appear in markets in dozens of countries.

  • Netflix user growth beats expectations, shares spike
    Finance
    Yahoo Finance

    Netflix user growth beats expectations, shares spike

    Netflix (NFLX) reported user growth that exceeded Wall Street expectations, underscoring a recovery for the online streamer following a rare miss in new user additions last quarter.The Los Gatos, California-based company brought on 6.96 million total new streamers, beating its own guidance of 5 million total member additions for the quarter. The company issued guidance that it would add 9.4 million new members in the fourth quarter of 2018. Netflix’s stock rose 13% in late trading Tuesday.